These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 38852521)
1. Modulation of gut microbiota on intestinal permeability: A novel strategy for treating gastrointestinal related diseases. Li Z; Wan M; Wang M; Duan J; Jiang S Int Immunopharmacol; 2024 Aug; 137():112416. PubMed ID: 38852521 [TBL] [Abstract][Full Text] [Related]
2. Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier. Liu Y; Huang W; Wang J; Ma J; Zhang M; Lu X; Liu J; Kou Y Front Immunol; 2021; 12():693479. PubMed ID: 34386004 [TBL] [Abstract][Full Text] [Related]
3. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis. Olivier S; Pochard C; Diounou H; Castillo V; Divoux J; Alcantara J; Leclerc J; Guilmeau S; Huet C; Charifi W; Varin TV; Daniel N; Foretz M; Neunlist M; Salomon BL; Ghosh P; Marette A; Rolli-Derkinderen M; Viollet B Mol Metab; 2021 May; 47():101183. PubMed ID: 33548500 [TBL] [Abstract][Full Text] [Related]
4. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases. Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839 [TBL] [Abstract][Full Text] [Related]
5. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Parker A; Fonseca S; Carding SR Gut Microbes; 2020; 11(2):135-157. PubMed ID: 31368397 [TBL] [Abstract][Full Text] [Related]
6. Gut barrier in health and disease: focus on childhood. Viggiano D; Ianiro G; Vanella G; Bibbò S; Bruno G; Simeone G; Mele G Eur Rev Med Pharmacol Sci; 2015; 19(6):1077-85. PubMed ID: 25855935 [TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Intestinal Trans-Epithelial Permeability. Allam-Ndoul B; Castonguay-Paradis S; Veilleux A Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899147 [TBL] [Abstract][Full Text] [Related]
8. Direct effects of alcohol on gut-epithelial barrier: Unraveling the disruption of physical and chemical barrier of the gut-epithelial barrier that compromises the host-microbiota interface upon alcohol exposure. Kuo CH; Wu LL; Chen HP; Yu J; Wu CY J Gastroenterol Hepatol; 2024 Jul; 39(7):1247-1255. PubMed ID: 38509796 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiota derived metabolites contribute to intestinal barrier maturation at the suckling-to-weaning transition. Beaumont M; Paës C; Mussard E; Knudsen C; Cauquil L; Aymard P; Barilly C; Gabinaud B; Zemb O; Fourre S; Gautier R; Lencina C; Eutamène H; Theodorou V; Canlet C; Combes S Gut Microbes; 2020 Sep; 11(5):1268-1286. PubMed ID: 32352849 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Di Vincenzo F; Del Gaudio A; Petito V; Lopetuso LR; Scaldaferri F Intern Emerg Med; 2024 Mar; 19(2):275-293. PubMed ID: 37505311 [TBL] [Abstract][Full Text] [Related]
11. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis. Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E Front Immunol; 2021; 12():635704. PubMed ID: 34054805 [TBL] [Abstract][Full Text] [Related]
12. The small intestine: barrier, permeability and microbiota. Stalla FM; Astegiano M; Ribaldone DG; Saracco GM; Pellicano R Minerva Gastroenterol (Torino); 2022 Mar; 68(1):98-110. PubMed ID: 33267569 [TBL] [Abstract][Full Text] [Related]
13. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders. Macchione IG; Lopetuso LR; Ianiro G; Napoli M; Gibiino G; Rizzatti G; Petito V; Gasbarrini A; Scaldaferri F Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8075-8083. PubMed ID: 31599433 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934 [TBL] [Abstract][Full Text] [Related]
15. Integrated Analyses of the Gut Microbiota, Intestinal Permeability, and Serum Metabolome Phenotype in Rats with Alcohol Withdrawal Syndrome. Yang F; Wei J; Shen M; Ding Y; Lu Y; Ishaq HM; Li D; Yan D; Wang Q; Zhang R Appl Environ Microbiol; 2021 Aug; 87(18):e0083421. PubMed ID: 34190609 [TBL] [Abstract][Full Text] [Related]
16. The Local Defender and Functional Mediator: Gut Microbiome. Yang H; Duan Z Digestion; 2018; 97(2):137-145. PubMed ID: 29310114 [TBL] [Abstract][Full Text] [Related]
17. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Stecher B Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088 [TBL] [Abstract][Full Text] [Related]
18. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Kinashi Y; Hase K Front Immunol; 2021; 12():673708. PubMed ID: 33968085 [TBL] [Abstract][Full Text] [Related]
19. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders. Keita ÅV; Söderholm JD Curr Opin Pharmacol; 2018 Dec; 43():66-71. PubMed ID: 30216901 [TBL] [Abstract][Full Text] [Related]
20. Microbiota-derived extracellular vesicles in interkingdom communication in the gut. Díaz-Garrido N; Badia J; Baldomà L J Extracell Vesicles; 2021 Nov; 10(13):e12161. PubMed ID: 34738337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]